In the present study, we chose ApoG2, the most potent derivative of gossypol with high affinity against anti-apoptotic Bcl-2 family members (pan-Bcl-2 inhibitor), including Bcl-2, Bcl-XL and Mcl-1 in tumor-targeted treatment (36). Here, BCL2 is linked to neoplasm.